A selective thromboxane A2 (TXA2) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression in oleic acid-induced lung injury in guinea pigs.

Source:http://linkedlifedata.com/resource/pubmed/id/19783866

Download in:

View as

General Info

PMID
19783866